Johan Hartman

Johan Hartman

Karolinska Institutet

H-index: 41

Europe-Sweden

About Johan Hartman

Johan Hartman, With an exceptional h-index of 41 and a recent h-index of 34 (since 2020), a distinguished researcher at Karolinska Institutet, specializes in the field of Breast cancer, tumor biology, pathology, oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse Outcomes

Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer

A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells

Abstract PO5-13-02: BRCA mutational profiles of endocrine-resistant breast cancer

Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay

Abstract PO4-07-05: Clinical evaluation of image-based risk profiling in breast cancer histopathology and comparison to an established gene expression assay

Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer

Johan Hartman Information

University

Position

Dept of Oncology-Pathology

Citations(all)

9959

Citations(since 2020)

5626

Cited By

6271

hIndex(all)

41

hIndex(since 2020)

34

i10Index(all)

80

i10Index(since 2020)

70

Email

University Profile Page

Karolinska Institutet

Google Scholar

View Google Scholar Profile

Johan Hartman Skills & Research Interests

Breast cancer

tumor biology

pathology

oncology

Top articles of Johan Hartman

Title

Journal

Author(s)

Publication Date

Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse Outcomes

bioRxiv

Maria Andreou

Marcin Jakalski

Katarzyna Duzowska

Natalia Filipowicz

Anna Kostecka

...

2024

Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer

Breast Cancer Research

Caroline Rönnlund

Emmanouil G Sifakis

Caroline Schagerholm

Qiao Yang

Emelie Karlsson

...

2024/2/7

A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells

Journal of Experimental & Clinical Cancer Research

Pedro Fonseca

Weiyingqi Cui

Nona Struyf

Le Tong

Ayushi Chaurasiya

...

2024/4/9

Abstract PO5-13-02: BRCA mutational profiles of endocrine-resistant breast cancer

Cancer Research

Emelie Karlsson

Caroline Schagerholm

Stephanie Robertson

Hosein Toosi

Emmanouil Sifakis

...

2024/5/2

Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study

British Journal of Surgery

Gunilla Rask

Charlotta Wadsten

Balazs Acs

Johan Hartman

Irma Fredriksson

...

2024/2

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay

Stephanie Robertson

Yinxi Wang

Wenwen Sun

Emelie Karlsson

Sandy Kang Lövgren

...

2023/12/1

Abstract PO4-07-05: Clinical evaluation of image-based risk profiling in breast cancer histopathology and comparison to an established gene expression assay

Cancer Research

Stephanie Robertson

Yinxi Wang

Wenwen Sun

Emelie Karlsson

Sandy Kang Lövgren

...

2024/5/2

Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer

Breast Cancer Research

Abhinav Sharma

Philippe Weitz

Yinxi Wang

Bojing Liu

Johan Vallon-Christersson

...

2024/1/29

Generative AI for virtual HE-staining of whole slide images of unstained breast cancer tissue

Cancer Research

Leena Latonen

Umair Khan

Sonja Koivukoski

Johan Hartman

Pekka Ruusuvuori

2024/3/22

Abstract PO4-01-05: The prognostic importance of biological pathway enrichment patterns in trastuzumab-treated early HER2-positive breast cancer

Cancer Research

Caroline Rönnlund

Qiao Yang

Caroline Schagerholm

Theodoros Foukakis

Irma Fredriksson

...

2024/5/2

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

Chowdhury Arif Jahangir

David B Page

Glenn Broeckx

Claudia A Gonzalez

Caoimbhe Burke

...

2024/1/17

Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study

Una Kjällquist

Nikolaos Tsiknakis

Balazs Acs

Sara Margolin

Luisa Edman Kessler

...

2024/3/19

Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga] Ga-ABY-025: Results from a Pilot Study

Journal of Nuclear Medicine

Renske Altena

Siri af Burén

August Blomgren

Emelie Karlsson

Antonios Tzortzakakis

...

2024/5/1

Resolving the haplotype complexity of colorectal cancer genomes with droplet barcode sequencing

Humam Siga

Pontus Höjer

Parham Pourbozorgi

Hooman Aghelpasand

Max Käller

...

2024

Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population …

The Lancet Regional Health–Europe

Balazs Acs

Johan Hartman

Demet Sönmez

Henrik Lindman

Anna LV Johansson

...

2024/3/19

CopyVAE: a variational autoencoder-based approach for copy number variation inference using single-cell transcriptomics

Bioinformatics

Semih Kurt

Mandi Chen

Hosein Toosi

Xinsong Chen

Camilla Engblom

...

2024/4/27

Abstract PO3-16-04: Distribution of intrinsic subtypes in endocrine-resistant and endocrine-sensitive breast cancer

Cancer Research

Caroline Schagerholm

Stephanie Robertson

Emelie Karlsson

Emmanouil Sifakis

Johan Hartman

2024/5/2

Survival outcomes, digital TILs, and on-treatment PET/CT during neoadjuvant therapy for HER2-positive breast cancer: results from the randomized PREDIX HER2 trial

Clinical Cancer Research

Alexios Matikas

Hemming Johansson

Per Grybäck

Judith Bjöhle

Balazs Acs

...

2023/2/1

241MO Patient characteristics and real-world outcomes in HER2 negative/ER zero and ER low patients treated as triple-negative breast cancer in Sweden 2008-2020

Annals of Oncology

I Fredriksson

B Acs

J Hartman

D Sönmez

H Lindman

2023/10/1

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast …

David B Page

Glenn Broeckx

Chowdhury Arif Jahangir

Sara Verbandt

Rajarsi R Gupta

...

2023/8

See List of Professors in Johan Hartman University(Karolinska Institutet)

Co-Authors

H-index: 123
Per Hall

Per Hall

Karolinska Institutet

H-index: 58
Valerie Speirs

Valerie Speirs

University of Aberdeen

H-index: 37
Johan Lindberg

Johan Lindberg

Karolinska Institutet

academic-engine